Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DX25F6AEM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $28,252
Award facts
- Contract value 100% obligated
- $28,251.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $28.3K by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order is scheduled for completion by September 18, 2025, with no set-aside designation applied. The award represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500M vehicle that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
This delivery order exemplifies the company's established role as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to provide branded and specialty medications to military health systems. Xolair (omalizumab), an injectable biologic used for allergic asthma and chronic urticaria management, represents the type of specialty pharmaceutical products regularly distributed through DMS Pharmaceutical Group's established logistics framework to military medical facilities across the nation.
Quick answers
Who was awarded contract SPE2DX25F6AEM?
SPE2DX25F6AEM was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 27, 2025.
How much is contract SPE2DX25F6AEM worth?
The government has obligated $28,252 on SPE2DX25F6AEM.
Is contract SPE2DX25F6AEM an order under another contract?
Yes. SPE2DX25F6AEM is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AEM competed?
The extent of competition for SPE2DX25F6AEM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award